SAN DIEGO, California (Reuters Health) - Nerve blocks, commonly given to patients with low back pain, don't seem to reduce pain, improve mood or cut the use of analgesic medications, a researcher ...

Here’s some spine-tingling news. New research suggests a drug already available on pharmacy shelves could help ease chronic lower back pain. It’s a welcome discovery for the millions of Americans who ...

A new study finds that ultrasound-guided thoracic paravertebral block (TPVB) is more effective than stellate ganglion block (SGB) for treating chronic upper arm pain, providing better pain relief and ...

Newer equipment and improved ultrasound imaging make femoral nerve blocks a more viable choice for post-operative pain relief in total joint replacements, allowing patients to block pain just where it ...

And the reasons behind its use might have more to do with financial gain than patient wellbeing. Writing in the British Medical Association's journal, The BMJ, a panel of experts says that ...

New research reveals that parathyroid hormone (PTH) could halt abnormal nerve growth in the spine, offering a revolutionary lifeline for millions living with debilitating lower back discomfort.

Low back pain (LBP) is one of the most common health problems worldwide, affecting people of all ages and placing a heavy burden on healthcare systems. Many patients experience persistent discomfort ...

A study led by doctors at the Medical University of South Carolina and UMass Chan Medical School found that ultrasound-guided nerve blocks helped kids with broken thigh bones, also known as femurs, ...

Each September is Pain Awareness Month. It is an opportunity to recognize the needs of the millions of people who live with chronic pain. According to the U.S. Pain Foundation, more than 51 million ...

An estimated 80% of the population will suffer from lower back pain at some point. The good news is that preventing it is a lot easier than treating it ...

PARSIPPANY, N.J., Jan. 07, 2025 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in the delivery of innovative, non-opioid pain therapies to transform the lives of ...